Navigation Links
ECLINSO Announces Partnership with XClinical
Date:3/2/2012

LYNDHURST, N.J., March 2, 2012 /PRNewswire-iReach/ -- ECLINSO AG, a leading provider of clinical information technology, consulting and business process outsourcing services, announced today that it has entered into a strategic partnership agreement with XClinical GmbH. XClinical is a leading eClinical technology solutions company, offering its CDISC-certified Electronic Data Capture (EDC) and Data Management (DM) system MARVIN and related tools such as the STUDY COMPOSER and the TABULATOR.

The combined solutions, ECLINSO's trialforce Platform and XClinical's EDC system MARVIN, offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CRO's) for capturing and managing their clinical data. Trialforce, a managed application platform, is fully compliant to the following industry standards 21 CFR 11, CDISC, HIPAA, W3C, and GCP with support for over 50 languages (including double byte languages such as Chinese). Trialforce is a cloud-based platform with no local software or hardware to support. Based on a Software as a Service (SaaS) pricing model there are minimal upfront costs, significantly lowering the initial licensing fees traditionally associated with EDC and Data Management solutions.

MARVIN can be used across all types of therapeutic areas; adapting to any type of clinical trial including Phase I-IV interventional studies, medical device trials, observational studies, registry trials, prevention studies, genetic investigations, diagnostic trials, and outcomes research. MARVIN is built on CDISC standards that enable pharmaceutical companies, CROs and MedTech companies to increase clinical trial efficiency. STUDY COMPOSER, the EDC design tool, offers an intuitive graphical point-and-click interface for defining a trial and creating relevant metadata. Study Composer automatically generates the eCRF design; the annotated CRF and data vali
'/>"/>

SOURCE ECLINSO
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... and SAN DIEGO , ... its parent company Eisai Co., Ltd. (Headquarters: ... , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Helen Torley , "NASDAQ: HALO") have signed a ... name: Halaven ® , "eribulin") in combination with Halozyme,s ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... ... 17-20, Currently, over 54,255 Trials with Locations in 154 Countries Are Taking ... ... Board (IRB), is,responsible for overseeing research and protecting the rights and welfare,of people participating in ...
... international lymphoma conference shows, investigational regimen resulted in 82 percent overall survival ... ... III clinical trial is presently being conducted in this ... patient population, LUGANO, Switzerland, June 9 ...
Cached Medicine Technology:ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 2ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 2Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 4
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons ... the unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. In ... founders of both companies have agreed to join their missions of purpose together to ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... users to clarify, edit and delete any message including ones already sent. , While ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, ... on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. ... this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit ...
(Date:7/31/2015)... Alexandria, VA (PRWEB) , ... July 31, 2015 ... ... Foundation) introduced its new store run by GoodThreads. The store can be accessed ... products and designs, many of which are customizable. The best part: whenever a ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... communicate. Rally Insurance Group, Inc. has re-branded their social media profiles to better ... personal way for consumers to communicate, find information, share insights and opinions. The ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... University of California, Berkeley, and Chilean researchers says that children ... water are more likely to succumb to lung cancer or ... adult life. ,It was found that the risk ... if the child's mother also drank the arsenic-contaminated water during ...
... affecting about 1% of the female population. Women with heavy ... undetected. Only about 5,000 women have been diagnosed in the ... for the Haemophilia Society says that about only 70% approach ... is a condition which leads to heavy or prolonged menstrual ...
... in Europe, reports a league table, to be published before ... of the treatment and encourages childless women to take part ... , When compared to the success rates of ... to attain a success rate of 28.6%. this is a ...
... Phobia is an anxiety disorder characterised by extreme and irrational ... know exactly what causes this. // ,To overcome ... in the trial stage. ,The remedy developed by ... which the body produces naturally in times of stress or ...
... patients should be given a set of legally-binding entitlements ... standards in the cancer services would help to avoid ... National Institute of Health and Clinical Excellence (Nice). ... would be standardized should include home care, appraisal of ...
... by almost two times since 1990 in America. Labor, delivery ... being increasingly manipulated to suit the whims and fancies of ... fan in Pittsburg told news reporters that she requested her ... not miss the game. After determining the safety of the ...
Cached Medicine News:Health News:Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life 2Health News:British fertility clinics have low success rates 2Health News:To Wait Or Not 2
... autoLog™ Autotransfusion System processes blood collected ... washed red blood cells for return ... time. This is achieved with only ... innovative bowl design, coupled with sophisticated ...
The hipGRIP® is a twenty piece modular lateral positioning system which provides positive pelvis control with an innovative positioning system....
The Simpulse®VariCare™ System provides an innovative system for enhanced wound management which emphasizes performance, simplicity, safety, value, and support....
... staples are especially useful in ... including anterior cruciate reconstruction. They ... fixation, tendon and ligament repair ... Four sizes are available, in ...
Medicine Products: